Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02473991
Recruitment Status : Completed
First Posted : June 17, 2015
Results First Posted : August 2, 2017
Last Update Posted : August 2, 2017
Sponsor:
Collaborator:
Ain Shams University
Information provided by (Responsible Party):
amr elsayed elsayed, Ain Shams Maternity Hospital

Brief Summary:
The aim of this prospective longitudinal study was to investigate the relationship between placental thickness during the second and third trimesters and placental and birth weights.

Condition or disease Intervention/treatment
Pregnancy Fetal Macrosomia Intrauterine Growth Restriction Radiation: ultrasound

Detailed Description:

The investigator will make certain that the appropriate informed consent process is in place to ensure that potential research subjects, or their authorized representatives, are fully informed about the nature and objectives of the study, the potential risk and benefits of study participation, and their right as research subjects.

All laboratory specimens, evaluation forms, reports, video recordings, and other records that leave the site will not include unique personal data to maintain subject confidentiality.

All patients provided an informed written consent after they were fully instructed about the investigation.The study was approved by ethical committee of Ain Shams University.

All recruited women were observed at the 1st trimester screening at antenatal clinic and assessed for baseline demographic and obstetric data including age, parity, body mass index (BMI) and past medical events. Smoking, alcohol and drug use were also determined.

At second and third trimester (15-20 and 30-34 weeks of gestation respectively), the maternal weight, weight gain, BMI, BMI gain and data of ultrasound examination were recorded. At the time of delivery after assessment of maternal weight as mentioned above, the birth weight (in grams), fetal sex, and mode of delivery were taken.

All pregnant women underwent ultrasound evaluation of placental thickness at the time of second trimester (15-20 weeks of gestation) as well as third trimester (30-34 weeks of gestation).

All sonographic examinations were performed trans-abdominal using a Medison X4 ultrasound machine Trans abdominal4.0 megahertz (MHz) probe at The Special Care Center for Fetus Unit at Ain Shams University Maternity Hospital.

The placental thickness was measured by placing the ultrasound transducer perpendicularly to the plane of the placenta, in the area of the cord insertion, near the mid-placental portion as described by Hoddick et al

Each evaluation was performed by one of two experienced sonographers of our hospital with minimum inter- and intra-observer variability.

After delivery, the placenta was weighed in grams as previously described by Azpurua et al.

Fetal weight (primary objective) and neonatal status and morbidity including baby Apgar scores, fetal distress or fetal death and admission to the neonatal intensive care unit were also determined. All the examinations and data recording were performed by two senior resident physicians.(secondary objective)

Layout table for study information
Study Type : Observational
Actual Enrollment : 395 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight
Study Start Date : March 2015
Actual Primary Completion Date : December 2016
Actual Study Completion Date : January 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Body Weight


Intervention Details:
  • Radiation: ultrasound
    The placental thickness was measured by placing the ultrasound transducer perpendicularly to the plane of the placenta, in the area of the cord insertion, near the mid-placental portion


Primary Outcome Measures :
  1. Fetal Weight (Fetal Weight at Birth) [ Time Frame: 9 months ]
    Fetal weight (fetal weight at birth) (in grams)

  2. Placental Thickness in Second Trimester [ Time Frame: 15-20 weeks of gestation ]
    placental thickness measured in millimeter

  3. Placental Thickness at 3rd Trimester [ Time Frame: 30-34 weeks of pregnancy ]

Biospecimen Retention:   Samples Without DNA
placenta is weighed in grams as described by Azpurua et al.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 30 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
uncomplicated pregnant women who will attend the outpatient clinic at Ain Shams University Maternity Hospital
Criteria

Inclusion Criteria:

  1. patient Aged between 18 and 45 years.
  2. singleton viable pregnancy.
  3. non scared uterus.

Exclusion Criteria:

  1. systemic illness (DM,Hypertension, renal disease, liver disease, sickle cell disease)
  2. known congenital fetal anomalies.
  3. multiple pregnancy.
  4. intra uterine fetal death.
  5. anatomical defect of pregnant uterus
  6. abnormally located placenta or placental anomalies
  7. morbid obesity
  8. missing records
  9. unwilling to incorporate in the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02473991


Locations
Layout table for location information
Egypt
Ain shams faculty of medicine
Cairo, Elabbasia, Egypt
Sponsors and Collaborators
Ain Shams Maternity Hospital
Ain Shams University
Investigators
Layout table for investigator information
Study Director: AHMED MEKLED, Professor Ain Shams University
Study Director: HAYTHAM SABAA, Lecturer Ain Shams University
Publications:
Layout table for additonal information
Responsible Party: amr elsayed elsayed, researcher for master degree, Ain Shams Maternity Hospital
ClinicalTrials.gov Identifier: NCT02473991    
Other Study ID Numbers: Master degree in Obs & gyn
First Posted: June 17, 2015    Key Record Dates
Results First Posted: August 2, 2017
Last Update Posted: August 2, 2017
Last Verified: April 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Fetal Growth Retardation
Fetal Macrosomia
Fetal Weight
Fetal Diseases
Pregnancy Complications
Growth Disorders
Pathologic Processes
Diabetes, Gestational
Pregnancy in Diabetics
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Birth Weight
Body Weight